Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-09

Clinical Trial Update: Rasburicase Treatment in Chronic Gouty Arthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating rasburicase treatment for chronic gout.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rasburicase (rasburicase)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Chronic Gout | Phase 4 | Status: UNKNOWN